RXRX
NASDAQ
$2.89
Recursion Pharmaceuticals Inc - Class A (RXRX)
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.25 (+150.87%)
Market Cap
$1.76B
Revenue 5Y CAGR
+59.35%
FCF 5Y CAGR
+31.49%
Free Cash Flow Yield
-18.55%
Price Chart
Valuation
Market Cap$1.76B
P/S26.45
P/B1.73
Profitability
Total Revenue (TTM)$66M
Gross Profit (TTM)-$429M
EBITDA-$501M
Operating Margin-1986%
EPS-$1.15
Financial Health
Free Cash Flow Yield-18.55%
Growth & Risk
EPS 5Y CAGR-10.03%
Revenue 5Y CAGR+59.35%
FCF 5Y CAGR+31.49%
Beta (5Y)2.62
Sharpe Ratio-0.62